CymitQuimica logo

CAS 2089288-03-7

:

Fórmula:C27H32FN5O2
InChI:InChI=1S/C27H32FN5O2/c1-18(2)33-26-21-14-20(22(28)15-23(21)29-17-24(26)31(3)27(33)34)19-8-9-25(30-16-19)35-13-7-12-32-10-5-4-6-11-32/h8-9,14-18H,4-7,10-13H2,1-3H3
Chave InChI:VQSZIPCGAGVRRP-UHFFFAOYSA-N
SMILES:CC(C)N1C2=C(C=NC3=CC(=C(C=C32)C4=CN=C(C=C4)OCCCN5CCCCC5)F)N(C1=O)C
Foram encontrados 8 produtos.
  • AZD1390

    CAS:
    Fórmula:C27H32FN5O2
    Pureza:98%
    Cor e Forma:Solid
    Peso molecular:477.5737

    Ref: IN-DA01EO9B

    100mg
    A consultar
    1mg
    64,00€
    5mg
    146,00€
    10mg
    195,00€
    2mg
    220,00€
    25mg
    384,00€
    50mg
    538,00€
  • azd1390

    CAS:
    azd1390
    Fórmula:C27H32FN5O2
    Pureza:≥95%
    Cor e Forma:Solid
    Peso molecular:477.57

    Ref: 54-BUP04108

    2mg
    165,00€
    5mg
    233,00€
    10mg
    329,00€
    25mg
    648,00€
    50mg
    825,00€
    100mg
    1.025,00€
  • azd1390

    CAS:
    AZD1390: Potent ATM inhibitor (IC50: 0.78 nM), >10,000-fold selectivity vs. PIKK enzymes.
    Fórmula:C27H32FN5O2
    Pureza:97.41% - 99.72%
    Cor e Forma:White Solid
    Peso molecular:477.5737
  • AZD1390

    CAS:
    Fórmula:C27H32FN5O2
    Peso molecular:477.58

    Ref: 4Z-K-031004

    5mg
    A consultar
    10mg
    A consultar
    25mg
    A consultar
    50mg
    A consultar
    100mg
    A consultar
  • AZD1390

    CAS:
    7-Fluoro-1-isopropyl-3-methyl-8-(6-(3-(piperidin-1-yl)propoxy)pyridin-3-yl)-1,3-dihydro-2H-imidazo[4,5-c]quinolin-2-one
    Fórmula:C27H32FN5O2
    Pureza:98%
    Peso molecular:477.57
  • azd1390

    CAS:
    Fórmula:C27H32FN5O2
    Peso molecular:477.6

    Ref: BE-RMCK020004

    1mg
    140,00€
  • AZD 1390

    Produto Controlado
    CAS:
    Fórmula:C27H32FN5O2
    Cor e Forma:Neat
    Peso molecular:477.574

    Ref: TR-A216035

    25mg
    15.866,00€
  • AZD1390

    CAS:
    AZD1390 is a positron-emitting drug that can be used to study the molecular mechanisms of cancer. It binds to receptors on the surface of cells, activating cell signaling pathways, and is currently being studied for use in the treatment of squamous carcinoma. AZD1390 is able to penetrate solid tumours and it has been found to be effective against some types of cancer. The clinical studies showed that AZD1390 was safe and well-tolerated in patients with advanced cancers and that it had an acceptable side effect profile. This drug also has pharmacokinetic properties which make it suitable as a therapeutic agent.
    Fórmula:C27H32FN5O2
    Pureza:Min. 95%
    Peso molecular:477.57 g/mol

    Ref: 3D-PID28803

    10mg
    739,00€
    25mg
    1.238,00€
    50mg
    1.980,00€